Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: ITC 5/2/13 Response/submission by Barnes & Nobles to Order 35

My question would be since this is the ITC do the discovery rules apply the same as they would like at the NCDC with Judge Gruell?

I know have been involved in cases where all discovery is due on a certain date for litigation for judgement awards.

Is it possible that the rules are different at the ITC which is why TPL produces more evidence the BN is attempting to discredit?

Share
New Message
Please login to post a reply